capital

Last year, 108 unique institutional funders made a total of 260 investments in North Carolina companies, according to a report from the Council for Entrepreneurial Development. The 2013 Innovators Report details the $461 million in equity investments, grants and awards received by firms, including support from venture investors, angel networks, foundations, federal agencies, competitions, crowdfunding and other sources. Life sciences firms generated the most activity with $275 million in 134 deals, driven by the biopharmaceutical industry.

U.S. angel investors returned to their pre-recession level of activity in 2013, according to the latest release from the University of New Hampshire’s Center for Venture Research (UNH CVR). Investment had plummeted during the economic crisis of 2007-09, and grew over the next few years. Last year however, investment dollars jumped by 8.3 percent and deals increased by 5.5 percent over the previous year. Total investments reached $24.8 billion in 2013, near the market high of $26 billion achieved in 2007.

Michigan now has 44 percent more venture capital firms and 86 percent more investment professionals than it did in 2009, according to a report released by the Michigan Venture Capital Association. While the state ranks near the middle of the pack for total venture investment dollars and per capita investment, the size of its venture capital community has shown strong growth over the past five years, led by healthy life science and information technology industries. The total amount of capital under management has also grown, from $1.1 billion to $1.6 billion during that period.

Inconsistent federal support for clean energy research and infrastructure projects in recent years has hampered the blossoming of an industry that has long been touted as a key part of the new American economy. As a result, states and local governments have stepped into the fray with clean energy funds, green banks and other tools to finance the development of the clean energy economy. A paper from the Brookings Institution explores another underutilized tool available to local governments, the bond market.

Massachusetts’ continuing success in the biopharmaceutical sector depends on finding new ways to fund startup and early stage research activities, according to a new strategic plan released by the Massachusetts Biotechnology Council (MassBio). The report cites recent data showing that life sciences venture capital has fallen by 50 percent over the past five years and many investors have turned to later stage investments.

Together, New York and the Mid-Atlantic region were home to as much angel investment activity as California, according to the 2013 Year in Review edition of the HALO Report, published by Silicon Valley Bank and the Angel Resource Institute. Last year, California continued its reign as the top single region for angel activity, with 18.6 percent of U.S. deals and 19.6 percent of dollars. For the first time however, the combined activity of New York and the other Mid-Atlantic states reached levels similar to California, with 18.6 percent of deals and 19.7 percent of dollars.